Is AbbVie a Millionaire Maker? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
After all, they aren't typically in the news for good reasons, and despite relying on the lifesaving medicines that they produce, most people aren't talking to their coworkers about how their products are going to be in every household or core enablers for some grand global trend. But as keen investors know, sometimes the best opportunities are lying ignored in plain sight. So let's take a minute to evaluate whether a timely investment in AbbVie could make you millions and under what conditions. Holding AbbVie will probably make you a bit wealthier AbbVie's value proposition to investors is that it's a differentiated and top-performing pharmaceutical company that has a knack for engaging in the right research and development (R&D) work to compete in lucrative drug markets and win. And when AbbVie wins, it can win big, which could drive major returns for shareholders over time. Take its medicine called Humira, for instance. Humira treats a variety of different conditions rangin
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneePR Newswire
- ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]Yahoo! Finance
- Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]Yahoo! Finance
- Whey Protein Market To Reach USD 16.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website